| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4072447 | Journal of Orthopaedic Science | 2010 | 8 Pages |
Abstract
Because of the risk of severe encephalopathy, we conclude that patients who have previously received cisplatin or who receive ifosfamide at doses â¥9 g/m2 require strict monitoring.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Takahiro Tajino, Shin-Ichi Kikuchi, Hitoshi Yamada, Akira Takeda, Shin-Ichi Konno,